Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Akers Biosciences, Inc.    AKER

AKERS BIOSCIENCES, INC.

(AKER)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
Valuation
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Capitalization1 19,86,2310,45,0114,13,64
Entreprise Value (EV)1 10,01,7010,2-0,458,64-6,04
P/E ratio -6,02x-0,67x-3,12x-0,17x-1,22x-0,50x
Yield ------
Capitalization / Revenue 4,47x2,94x3,50x1,49x8,47x2,31x
EV / Revenue 2,27x0,80x3,45x-0,13x5,19x-3,83x
EV / EBITDA -3,52x-0,22x-2,44x0,07x-1,19x1,75x
Price to Book 1,34x0,99x3,06x1,02x2,42x0,59x
Nbr of stocks (in thousands) 25,826,828,41955201 137
Reference price (USD) 76623236525,727,13,20
Last update 03/30/201604/11/201707/13/201804/01/201903/25/202003/25/2020
1 USD in Million
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net sales1 4,432,122,963,351,671,58
EBITDA1 -2,85-7,62-4,19-6,36-7,26-3,45
Operating profit (EBIT)1 -3,20-7,92-4,47-6,61-7,49-3,53
Operating Margin -72,4%-374%-151%-197%-450%-224%
Pre-Tax Profit (EBT)1 -3,13-9,58-3,30-7,37-10,8-3,89
Net income1 -3,13-9,31-3,30-7,37-10,8-3,89
Net margin -70,6%-440%-112%-220%-651%-247%
EPS2 -127-348-117-151-22,3-6,35
Dividend per Share ------
Last update 03/30/201604/11/201707/13/201804/01/201903/25/202003/25/2020
1 USD in Million
2 USD
Balance Sheet Analysis
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net Debt1 ------
Net Cash position1 9,724,520,155,475,469,68
Leverage (Debt / EBITDA) 3,41x0,59x0,03x0,86x0,75x2,80x
Free Cash Flow1 0,20-3,16-3,61-2,81-3,17-1,60
ROE (Net Profit / Equities) -33,0%-87,0%-66,1%-135%-162%-51,2%
Shareholders' equity1 9,4610,75,005,476,697,59
ROA (Net Profit / Asset) -17,6%-39,7%-41,9%-57,3%-54,6%-23,6%
Assets1 17,723,57,8912,919,916,5
Book Value Per Share2 57423411925,111,25,38
Cash Flow per Share2 17,714,22,561,900,350,30
Capex1 0,020,110,120,050,07-
Capex / Sales 0,56%5,34%4,16%1,62%4,10%-
Last update 03/30/201604/11/201707/13/201804/01/201903/25/202003/25/2020
1 USD in Million
2 USD
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (USD)
22 326 867
Net sales (USD)
1 577 033
Number of employees
12
Sales / Employee (USD)
131 419
Free-Float
84,0%
Free-Float capitalization (USD)
18 744 276
Avg. Exchange 20 sessions (USD)
1 205 609
Average Daily Capital Traded
5,40%
EPS & Dividend